Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors

✍ Scribed by L Rhoda Molife,Li Yan,Joanna Vitfell-Rasmussen…

• Book ID: 121576486
• Publisher: BioMed Central
• Year: 2014
• Tongue: English
• Weight: 389 KB
• Volume: 7
• Category: Article
• ISSN: 1756-8722
• DOI: 10.1186/1756-8722-7-1